621. MENTAL HEALTH AUSTRALIA GENERAL CLINICAL TRIAL NETWORK (MAGNET) – CONNECTING KNOWLEDGE FOR BETTER MENTAL HEALTH OUTCOMES

Abstract Background Mental Health Australia General Clinical Trials Network (MAGNET) is the first network in Australia dedicated to clinical trials in adult mental health, aiming to advance prevention, diagnosis, treatment, and recovery. Funded through the 2020 Million Minds Mission grant by the Australian Medical Research Future Fund (MRFF), MAGNET’s goal is to facilitate large-scale, coordinated clinical trials at both national and international levels. By fostering collaboration, MAGNET seeks to drive transformative mental health research, addressing critical unmet needs and answering complex questions that require the scale and expertise of a unified network. Aims & Objectives MAGNET's overarching vision is to be a leading network internationally for high-quality mental health clinical trials that serve community needs. MAGNET’s mission is to unify and improve adult mental health clinical trial research and translation in Australia. MAGNET aims to create a reusable, sustainable and shared infrastructure to strengthen the capacity, quality, effectiveness, and translation of mental health clinical trials (CTs). Method MAGNET is a collaboration between over 50+ Australian institutions and 600+ leading researchers, clinicians, and lived experience research partners in mental health aiming to improve the quality, capacity, reach and translation of clinical trials. Results In collaboration with the mental health community, MAGNET has established seven platform resources designed to enhance the quality and capacity of clinical trials. MAGNET also supports four signature trials, leveraging these platforms to provide essential resources and expertise for trial design and implementation while minimising duplication. MAGNET has established a trial endorsement process to support transformative mental health research, targeting critical gaps and unresolved questions at both national and international levels. At the core of MAGNET’s governance are Lived Experience Research Partners, First Nations collaborators, researchers, and clinicians, whose active involvement is essential across all aspects of the network. Through strategic planning, MAGNET is committed to ensuring that clinical trials drive significant progress in prevention, diagnosis, treatment, and recovery worldwide. Discussion & Conclusions MAGNET is dedicated to enabling scalable, high-quality, and translatable mental health clinical trials that meet community needs. The network warmly invites national and international researchers and partners to collaborate in the development of mental health clinical trials.

Authors

Institutions

Publication Details

Journal
The International Journal of Neuropsychopharmacology
Published
2025-08-01
DOI
https://doi.org/10.1093/ijnp/pyaf052.091
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

621. MENTAL HEALTH AUSTRALIA GENERAL CLINICAL TRIAL NETWORK (MAGNET) – CONNECTING KNOWLEDGE FOR BETTER MENTAL HEALTH OUTCOMES

Dan J. Siskind, Cathrine Mihalopoulos, Anthony Rodgers, Catherine Kaylor‐Hughes et al.
The International Journal of Neuropsychopharmacology
Schizophrenia research and treatment
article

621. MENTAL HEALTH AUSTRALIA GENERAL CLINICAL TRIAL NETWORK (MAGNET) – CONNECTING KNOWLEDGE FOR BETTER MENTAL HEALTH OUTCOMES

Dan J. Siskind, Cathrine Mihalopoulos, Anthony Rodgers, Catherine Kaylor‐Hughes, Ayla Barutchu, Christine Schultz, A Calear, Preet Kaur, Suzie Lavoie, Ravi Iyer, Philip J. Batterham, Scott Richard Clark, Carla Haroutonian, Emily G. McDonald, Sean Hood, A O’Neil, Christopher G. Davey, Leilani Darwin, Susan Lee Rossell, Michael Berk, Suresh Sundram, A Markus, Kerry Mills, E Carbines
article en

Abstract

Abstract Background Mental Health Australia General Clinical Trials Network (MAGNET) is the first network in Australia dedicated to clinical trials in adult mental health, aiming to advance prevention, diagnosis, treatment, and recovery. Funded through the 2020 Million Minds Mission grant by the Australian Medical Research Future Fund (MRFF), MAGNET’s goal is to facilitate large-scale, coordinated clinical trials at both national and international levels. By fostering collaboration, MAGNET seeks to drive transformative mental health research, addressing critical unmet needs and answering complex questions that require the scale and expertise of a unified network. Aims & Objectives MAGNET's overarching vision is to be a leading network internationally for high-quality mental health clinical trials that serve community needs. MAGNET’s mission is to unify and improve adult mental health clinical trial research and translation in Australia. MAGNET aims to create a reusable, sustainable and shared infrastructure to strengthen the capacity, quality, effectiveness, and translation of mental health clinical trials (CTs). Method MAGNET is a collaboration between over 50+ Australian institutions and 600+ leading researchers, clinicians, and lived experience research partners in mental health aiming to improve the quality, capacity, reach and translation of clinical trials. Results In collaboration with the mental health community, MAGNET has established seven platform resources designed to enhance the quality and capacity of clinical trials. MAGNET also supports four signature trials, leveraging these platforms to provide essential resources and expertise for trial design and implementation while minimising duplication. MAGNET has established a trial endorsement process to support transformative mental health research, targeting critical gaps and unresolved questions at both national and international levels. At the core of MAGNET’s governance are Lived Experience Research Partners, First Nations collaborators, researchers, and clinicians, whose active involvement is essential across all aspects of the network. Through strategic planning, MAGNET is committed to ensuring that clinical trials drive significant progress in prevention, diagnosis, treatment, and recovery worldwide. Discussion & Conclusions MAGNET is dedicated to enabling scalable, high-quality, and translatable mental health clinical trials that meet community needs. The network warmly invites national and international researchers and partners to collaborate in the development of mental health clinical trials.

The International Journal of NeuropsychopharmacologyVol. 28(Supplement_2)
Australian National University (AU), The University of Sydney (AU), Deakin University (AU), The University of Queensland (AU), The University of Melbourne (AU), Black Dog Institute (AU), The University of Western Australia (AU), The George Institute for Global Health (GB), House of Representatives (NL), Orygen Youth Health (AU), Assembly of First Nations (CA), Office of the Chief Scientist (IL), The George Institute for Global Health (AU), Monash Health (AU), First Nations Development Institute (US), Monash University (AU), The University of Adelaide (AU), Swinburne University of Technology (AU)
Openalex Percentile: Top 75%
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.